Logo Image

Shorts

David Rimm, MD, PhD, said that pathologists play a crucial role in educating oncologists about the "science behind the assay," helping oncologists understand the robustness, sensitivity, and specificity of different tests, which can have varying levels of accuracy and precision.
0:39
Looking Beyond Genomics in Precision Medicine for Cancer Care
a year ago
Elizabeth Kessler, MD highlighted a new target that oncologists should be aware of: the combination of niraparib, abiraterone, and prednisone in combination with an ADT backbone. which has shown a progression-free survival benefit and a trend toward an overall survival benefit.
1:29
Spotlighting Imaging/Therapuetic Advances Hormone Sensitive Prostate Cancer
a year ago
by
Ben Garmezy, MD(+1 more)
Dosing Considerations for Optimizing Ruxolitinib Efficacy in Myelofibrosis
0:30
Dosing Considerations for Optimizing Ruxolitinib Efficacy in Myelofibrosis
a year ago
by
Francesca Palandri, MD, PhD
Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute, spoke with different experts about their localized therapy perspectives during the morning sessions from World GU.
1:22
Highlighting Advances in Localized Therapy for Genitourinary Cancers
a year ago
by
Manojkumar Bupathi, MD, MS(+3 more)
Kerry R. Schaffer, MD, assistant professor in the Department of Medicine at the Vanderbilt Ingram Cancer Center and genitourinary oncologist, discussed the evolving role of radioligand therapy and imaging criteria in prostate cancer at the 2025 World Conference on Genitourinary Cancers.
1:02
Advancing Radioligand Therapy and Imaging Criteria in Prostate Cancer
a year ago
by
Benjamin Garmezy, MD(+1 more)
In patients with ES-SCLC, a population that has historically had limited treatment options after initial platinum-based chemotherapy, the recent accelerated approval of tarlatamab marks a significant advancement.
0:53
Offering Hope for Relapsed Brain Metastatic ES-SCLC With Tarlatamab
a year ago
by
Bingnan Zhang, MD, MBA
Although more recent drugs with a different mechanism of action are continuing to improve the treatment landscape, there is still work to be done to improve quality of life and achieve a cure for patients with chronic myeloid leukemia.
0:35
Outlining Chronic Myeloid Leukemia Advancements Through the Decades
a year ago
by
Jorge E. Cortes, MD
A multidisciplinary discussion may help in developing optimal treatment strategies for genitourinary cancers cases not covered by standard guidelines.
1:30
Optimizing Care Through Multidisciplinary Collaboration in GU Cancers
a year ago
by
Benjamin Garmezy, MD(+1 more)
Ronald Bleday, MD, colorectal surgeon, touched upon his experience with an Enhanced Recovery after Surgery perioperative approach for pain management for patients with colorectal cancer.
0:34
Managing Narcotic Use in Perioperative CRC Care
a year ago
by
Ronald Bleday, MD
Michael William Kendall, MD, a primary care physician specializing in cancer survivorship, emphasized the importance of timely discussions surrounding sexual health.
1:30
Discussing Sexual Health in Oncologic Practice
a year ago
by
Micheal William Kendall, MD
While weight loss can be a compelling factor for a cancer diagnosis, Denise B. Reynolds, RD, does not promote weight loss during active treatment, instead, focusing on helping patients maintain their weight and nutritional status.
1:17
Managing Cancer-Related Adverse Effects Through Nutrition and Wellness
a year ago
by
Denise B. Reynolds, RD
McFarland emphasized the need for a new approach, moving past the "see one, do one, teach one" model common among many oncologists.
1:19
Bridging the Psycho-Oncology Gap in Body Image Management
a year ago
by
Daniel C. McFarland, DO
Michelle Fingeret, PhD, suggests humanizing language in patients who may be experiencing body image concerns following cancer treatment.
1:29
Challenging Negative Body Image Language in Psycho-Oncology
a year ago
by
Michelle Fingeret, PhD
In a recent interview with CancerNetwork, Geraldine O’Sullivan Coyne, MD, MRCPI, PhD, expressed her delight and humility at being named leader of the Northwell Health Start Center for Cancer Research Unit.
1:16
Expanding Early Phase Trial Access Through START
a year ago
by
Geraldine O’Sullivan Coyne, MD, MRCPI, PhD